Based upon the concept of “Knowledge-Based Drug Discovery”, KMS has created a proprietary molecular design platform featured with:

World Traditional Drug Patent Database

180 thousand Prescriptions

9 thousand natural product materials

TCM Databases

22 thousand regular prescriptions, 2 thousand special prescriptions, and 72 thousand prescriptions with clinic data

8808 TCM materials

30 thousand chemical structures for active TCM components

120 thousand bioactivity data

Virtual Compound Database

More than 30 compound providers all over the world

More than 11 million compounds

Drug-like Compounds in Stock

Purity > 95%

More than three thousand compounds

Availability > 1-50g

Drug Design Platform

Drug Design Platform

Covers protein data from Swiss-Prot，PDB，TrEMBL，RefSeq，Ensembl, and IPI databases. Can conduct similarity searches on sequence, structure, and binding site

Special Toolkits for Drug Discovery

Algorithms to derive privileged structures from TCM

Seek targets for TCM

ADMET Predictions